The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer
The tumor microenvironment (TME) has been a major focus of research in recent years as a crucial factor in the development and progression of bladder cancer. Unfortunately, the precise composition of TME, particularly the immunological and stromal components, remains unknown. In this work, we downlo...
Saved in:
Main Authors: | Jun Jiang, Yan Zhan, Jun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/7952706 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypochondroplasia, Acanthosis Nigricans, and Insulin Resistance in a Child with FGFR3 Mutation: Is It Just an Association?
by: Manal Mustafa, et al.
Published: (2014-01-01) -
Fibroblast Growth Factor Receptor 3 (FGFR3)–Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas
by: Haiyan Dai, et al.
Published: (2001-01-01) -
De Novo Heterozygous Mutation in FGFR2 Causing Type II Pfeiffer Syndrome
by: Rafat Mosalli, et al.
Published: (2022-01-01) -
Titin gene mutations enhance radiotherapy efficacy via modulation of tumour immune microenvironment in rectum adenocarcinoma
by: Hengchang Liu, et al.
Published: (2025-01-01) -
Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer
by: Ke Zhu, et al.
Published: (2021-01-01)